ARK Invest's position in ILMN, updated every trading day. Data as of 2026-11-12.
| Fund | Shares | Value | Weight | Rank |
|---|---|---|---|---|
| ARKK | 337,192 | $70.7M | 0.97% | #34 |
| ARKG | 416,694 | $87.3M | 4.42% | #9 |
| Trade day | Fund | Side | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-04 | ARKG | Buy | Added | 4,524 | $1.0M |
| 2026-11-03 | ARKG | Buy | Added | 6,842 | $1.6M |
| 2026-11-02 | ARKG | Buy | Added | 7,219 | $1.6M |
| 2026-10-30 | ARKK | Buy | Added | 43,130 | $10.2M |
| 2026-10-08 | ARKK | Sell | Trimmed | 105,321 | $27.9M |
| 2026-09-14 | ARKK | Sell | Trimmed | 9,327 | $1.9M |
| 2026-08-19 | ARKK | Sell | Trimmed | 15,613 | $3.2M |
| 2026-08-18 | ARKK | Sell | Trimmed | 32,648 | $6.1M |
| 2026-07-29 | ARKK | Sell | Trimmed | 2,917 | $568K |
| 2026-07-20 | ARKK | Sell | Trimmed | 16,027 | $3.0M |
| 2026-07-16 | ARKK | Sell | Trimmed | 28,117 | $5.3M |
| 2026-07-08 | ARKK | Sell | Trimmed | 45,232 | $8.5M |
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and…
See ILMN's full ARK history since 2024, ARK's estimated cost basis, the conviction score and buy/sell alerts.
Open ILMN on FundWake →Data comes from ARK Invest's public daily holdings and trade files. FundWake is not affiliated with ARK Invest. Nothing here is investment advice.